PortfoliosLab logoPortfoliosLab logo
RLMD vs. SLV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

RLMD vs. SLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Relmada Therapeutics, Inc. (RLMD) and iShares Silver Trust (SLV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RLMD achieves a 42.65% return, which is significantly higher than SLV's -13.49% return. Over the past 10 years, RLMD has underperformed SLV with an annualized return of -3.73%, while SLV has yielded a comparatively higher 12.68% annualized return.


RLMD

1D
2.38%
1M
-2.13%
YTD
42.65%
6M
53.45%
1Y
915.48%
3Y*
40.77%
5Y*
-26.52%
10Y*
-3.73%

SLV

1D
-5.40%
1M
-18.48%
YTD
-13.49%
6M
-14.05%
1Y
69.08%
3Y*
39.38%
5Y*
18.31%
10Y*
12.68%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RLMD vs. SLV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
RLMD
Relmada Therapeutics, Inc.
42.65%828.85%-87.44%18.62%-84.51%-29.75%-17.77%747.83%53.33%-31.19%
SLV
iShares Silver Trust
-13.49%144.66%20.89%-1.09%2.37%-12.45%47.30%14.88%-9.19%5.82%

Correlation

The correlation between RLMD and SLV is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (10Y)
Calculated over the trailing 10-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Oct 9, 2014

0.08

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RLMD vs. SLV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RLMD
RLMD Risk / Return Rank: 9999
Overall Rank
RLMD Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
RLMD Sortino Ratio Rank: 9999
Sortino Ratio Rank
RLMD Omega Ratio Rank: 9797
Omega Ratio Rank
RLMD Calmar Ratio Rank: 100100
Calmar Ratio Rank
RLMD Martin Ratio Rank: 100100
Martin Ratio Rank

SLV
SLV Risk / Return Rank: 3131
Overall Rank
SLV Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
SLV Sortino Ratio Rank: 2929
Sortino Ratio Rank
SLV Omega Ratio Rank: 4040
Omega Ratio Rank
SLV Calmar Ratio Rank: 3030
Calmar Ratio Rank
SLV Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RLMD vs. SLV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Relmada Therapeutics, Inc. (RLMD) and iShares Silver Trust (SLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RLMDSLVDifference
Sharpe ratioReturn per unit of total volatility

+6.39

Sortino ratioReturn per unit of downside risk

+4.31

Omega ratioGain probability vs. loss probability

1.65

1.25

+0.40

Calmar ratioReturn relative to maximum drawdown

33.70

1.47

+32.23

Martin ratioReturn relative to average drawdown

75.27

3.16

+72.11

RLMD vs. SLV - Sharpe Ratio Comparison

The current RLMD Sharpe Ratio is 7.54, which is higher than the SLV Sharpe Ratio of 1.15. The chart below compares the historical Sharpe Ratios of RLMD and SLV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RLMD vs. SLV - Drawdown Comparison

The maximum RLMD drawdown since its inception was -99.66%, which is greater than SLV's maximum drawdown of -76.28%. Use the drawdown chart below to compare losses from any high point for RLMD and SLV.


Loading charts...

Drawdown Indicators


RLMDSLVDifference

Max Drawdown

Largest peak-to-trough decline

-99.66%

-76.28%

-23.38%

Max Drawdown (1Y)

Largest decline over 1 year

-27.44%

-47.23%

+19.79%

Max Drawdown (3Y)

Largest decline over 3 years

-96.30%

-47.23%

-49.07%

Max Drawdown (5Y)

Largest decline over 5 years

-99.32%

-47.23%

-52.09%

Max Drawdown (10Y)

Largest decline over 10 years

-99.50%

-47.23%

-52.27%

Current Drawdown

Current decline from peak

-90.74%

-47.23%

-43.51%

Average Drawdown

Average peak-to-trough decline

-79.72%

-44.65%

-35.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.39%

21.91%

-9.52%

Volatility

RLMD vs. SLV - Volatility Comparison

Relmada Therapeutics, Inc. (RLMD) has a higher volatility of 16.62% compared to iShares Silver Trust (SLV) at 14.34%. This indicates that RLMD's price experiences larger fluctuations and is considered to be riskier than SLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RLMDSLVDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.62%

14.34%

+2.28%

Volatility (6M)

Calculated over the trailing 6-month period

67.85%

59.27%

+8.58%

Volatility (1Y)

Calculated over the trailing 1-year period

122.87%

60.33%

+62.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

116.39%

36.59%

+79.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

114.22%

32.09%

+82.13%

Dividends

RLMD vs. SLV - Dividend Comparison

Neither RLMD nor SLV has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


RLMD and SLV have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RLMD has higher volatility (16.62%) compared to SLV (14.34%). In terms of maximum drawdown, RLMD dropped -99.66% vs SLV's -76.28%.

RLMD currently has the higher Sharpe Ratio (7.54 vs 1.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RLMD and SLV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer